Authors: Bewick, M Conlon, M Gerard, S Lee, H Parissenti, AM Zhang, L Gluck, S Lafrenie, RM

Citation: M. Bewick et al., HER-2 expression is a prognostic factor in patients with metastatic breastcancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support, BONE MAR TR, 27(8), 2001, pp. 847-853

Authors: Andrews, PA Compton, F Koffman, CG Bewick, M Chang, RWS

Citation: Pa. Andrews et al., Prediction of outcome in non-heart-beating kidney transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1121-1124

Authors: Fredericks, S Murray, JF Bewick, M Chang, R Collinson, PO Carter, ND Holt, DW

Citation: S. Fredericks et al., Cardiac troponin T and creatine kinase MB are not increased in exterior oblique muscle of patients with renal failure, CLIN CHEM, 47(6), 2001, pp. 1023-1030

Authors: Fredericks, S Chang, R Gregson, H Bewick, M Collinson, PO Gaze, D Carter, ND Holt, DW

Citation: S. Fredericks et al., Circulating cardiac troponin-T in patients before and after renal transplantation, CLIN CHIM A, 310(2), 2001, pp. 199-203

Authors: MacPhee, IAM Spreafico, S Bewick, M Davis, C Eastwood, JB Johnston, A Lee, T Holt, DW

Citation: Iam. Macphee et al., Pharmacokinetics of mycophenolate mofetil in patients with end-stage renalfailure, KIDNEY INT, 57(3), 2000, pp. 1164-1168

Authors: Bewick, M Chadderton, T Conlon, M Lafrenie, R Morris, D Stewart, D Gluck, S

Citation: M. Bewick et al., Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support, BONE MAR TR, 24(4), 1999, pp. 377-384